Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Mauro Sousa De Almeida
1, 2, 3, 4, 5
,
Eva Susnik
1, 2, 3, 4, 5
,
Barbara Drasler
1, 2, 3, 4, 5
,
Patricia Taladriz Blanco
1, 2, 3, 4, 5
,
Alke Petri Fink
1, 2, 3, 4, 5, 6, 7
,
B Rothen-Rutishauser
1, 2, 3, 4, 5
1
2
Adolphe Merkle Institute
4
1700 Fribourg
|
5
SWITZERLAND
|
7
DEPARTMENT OF CHEMISTRY
Publication type: Journal Article
Publication date: 2021-03-05
scimago Q1
wos Q1
SJR: 11.467
CiteScore: 73.2
Impact factor: 39.0
ISSN: 03060012, 14604744
PubMed ID:
33666625
General Chemistry
Abstract
Nanoparticles (NPs) have attracted considerable attention in various fields, such as cosmetics, the food industry, material design, and nanomedicine. In particular, the fast-moving field of nanomedicine takes advantage of features of NPs for the detection and treatment of different types of cancer, fibrosis, inflammation, arthritis as well as neurodegenerative and gastrointestinal diseases. To this end, a detailed understanding of the NP uptake mechanisms by cells and intracellular localization is essential for safe and efficient therapeutic applications. In the first part of this review, we describe the several endocytic pathways involved in the internalization of NPs and we discuss the impact of the physicochemical properties of NPs on this process. In addition, the potential challenges of using various inhibitors, endocytic markers and genetic approaches to study endocytosis are addressed along with the principal (semi) quantification methods of NP uptake. The second part focuses on synthetic and bio-inspired substances, which can stimulate or decrease the cellular uptake of NPs. This approach could be interesting in nanomedicine where a high accumulation of drugs in the target cells is desirable and clearance by immune cells is to be avoided. This review contributes to an improved understanding of NP endocytic pathways and reveals potential substances, which can be used in nanomedicine to improve NP delivery.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
|
|
|
ACS Nano
25 publications, 3.06%
|
|
|
Journal of Controlled Release
25 publications, 3.06%
|
|
|
Pharmaceutics
24 publications, 2.94%
|
|
|
Nanoscale
20 publications, 2.45%
|
|
|
ACS applied materials & interfaces
19 publications, 2.33%
|
|
|
Small
17 publications, 2.08%
|
|
|
Nanomaterials
16 publications, 1.96%
|
|
|
Chemical Engineering Journal
13 publications, 1.59%
|
|
|
Journal of Nanobiotechnology
13 publications, 1.59%
|
|
|
Advanced healthcare materials
13 publications, 1.59%
|
|
|
International Journal of Pharmaceutics
12 publications, 1.47%
|
|
|
Advanced Functional Materials
11 publications, 1.35%
|
|
|
Journal of Materials Chemistry B
11 publications, 1.35%
|
|
|
International Journal of Molecular Sciences
10 publications, 1.23%
|
|
|
International Journal of Biological Macromolecules
10 publications, 1.23%
|
|
|
Journal of Drug Delivery Science and Technology
10 publications, 1.23%
|
|
|
International Journal of Nanomedicine
8 publications, 0.98%
|
|
|
Advanced Science
8 publications, 0.98%
|
|
|
Angewandte Chemie - International Edition
8 publications, 0.98%
|
|
|
Angewandte Chemie
8 publications, 0.98%
|
|
|
Journal of the American Chemical Society
8 publications, 0.98%
|
|
|
Molecules
7 publications, 0.86%
|
|
|
Nature Communications
7 publications, 0.86%
|
|
|
Scientific Reports
7 publications, 0.86%
|
|
|
Nano Letters
7 publications, 0.86%
|
|
|
Acta Biomaterialia
7 publications, 0.86%
|
|
|
Biomaterials Science
7 publications, 0.86%
|
|
|
ACS Applied Bio Materials
7 publications, 0.86%
|
|
|
ACS Applied Nano Materials
6 publications, 0.74%
|
|
|
5
10
15
20
25
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
243 publications, 29.78%
|
|
|
Wiley
112 publications, 13.73%
|
|
|
American Chemical Society (ACS)
101 publications, 12.38%
|
|
|
Springer Nature
98 publications, 12.01%
|
|
|
MDPI
91 publications, 11.15%
|
|
|
Royal Society of Chemistry (RSC)
73 publications, 8.95%
|
|
|
Taylor & Francis
20 publications, 2.45%
|
|
|
Frontiers Media S.A.
17 publications, 2.08%
|
|
|
Cold Spring Harbor Laboratory
10 publications, 1.23%
|
|
|
IOP Publishing
7 publications, 0.86%
|
|
|
Oxford University Press
6 publications, 0.74%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 0.74%
|
|
|
Polymer Society of Korea
2 publications, 0.25%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 0.25%
|
|
|
Walter de Gruyter
2 publications, 0.25%
|
|
|
Tech Science Press
1 publication, 0.12%
|
|
|
Beilstein-Institut
1 publication, 0.12%
|
|
|
Chinese Society of Rare Earths
1 publication, 0.12%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.12%
|
|
|
Optica Publishing Group
1 publication, 0.12%
|
|
|
Hindawi Limited
1 publication, 0.12%
|
|
|
Cambridge University Press
1 publication, 0.12%
|
|
|
Pleiades Publishing
1 publication, 0.12%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.12%
|
|
|
Oriental Scientific Publishing Company
1 publication, 0.12%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.12%
|
|
|
Southwest State University
1 publication, 0.12%
|
|
|
OAE Publishing Inc.
1 publication, 0.12%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.12%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
816
Total citations:
816
Citations from 2024:
465
(56.99%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sousa De Almeida M. et al. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine // Chemical Society Reviews. 2021. Vol. 50. No. 9. pp. 5397-5434.
GOST all authors (up to 50)
Copy
Sousa De Almeida M., Susnik E., Drasler B., Taladriz Blanco P., Petri Fink A., Rothen-Rutishauser B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine // Chemical Society Reviews. 2021. Vol. 50. No. 9. pp. 5397-5434.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/D0CS01127D
UR - https://xlink.rsc.org/?DOI=D0CS01127D
TI - Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
T2 - Chemical Society Reviews
AU - Sousa De Almeida, Mauro
AU - Susnik, Eva
AU - Drasler, Barbara
AU - Taladriz Blanco, Patricia
AU - Petri Fink, Alke
AU - Rothen-Rutishauser, B
PY - 2021
DA - 2021/03/05
PB - Royal Society of Chemistry (RSC)
SP - 5397-5434
IS - 9
VL - 50
PMID - 33666625
SN - 0306-0012
SN - 1460-4744
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Sousa De Almeida,
author = {Mauro Sousa De Almeida and Eva Susnik and Barbara Drasler and Patricia Taladriz Blanco and Alke Petri Fink and B Rothen-Rutishauser},
title = {Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine},
journal = {Chemical Society Reviews},
year = {2021},
volume = {50},
publisher = {Royal Society of Chemistry (RSC)},
month = {mar},
url = {https://xlink.rsc.org/?DOI=D0CS01127D},
number = {9},
pages = {5397--5434},
doi = {10.1039/D0CS01127D}
}
Cite this
MLA
Copy
Sousa De Almeida, Mauro, et al. “Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.” Chemical Society Reviews, vol. 50, no. 9, Mar. 2021, pp. 5397-5434. https://xlink.rsc.org/?DOI=D0CS01127D.